A precise pharmacodynamic study showing the advantage of a marked reduction in cardiotoxicity in continuous infusion of doxorubicin.

Source:http://linkedlifedata.com/resource/pubmed/id/16966272

Download in:

View as

Triples

General Info

PMID
16966272